Signify Bio is a biotechnology company transforming the development of in situ protein therapeutics by leveraging the human body’s natural ability to produce proteins. Guided by its mission to create personalized medicines for all, Signify combines the precision of signal peptide engineered control with the speed and versatility of mRNA encoded design. The company’s SEND platform and iPhos lipid nanoparticles enable targeted and localized delivery of therapeutic proteins, addressing significant unmet needs across various diseases. Through innovative science, Signify Bio is committed to advancing solutions that make a meaningful difference for patients worldwide.
Company Details
- Employees
- 6
- Founded
- -
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://signifybio.com/
Signify Bio Questions
Signify Bio's website is https://signifybio.com/
Signify Bio's LinkedIn profile is https://www.linkedin.com/company/signify-bio
Signify Bio has
6 employees.
View email and phone details for 6
employees at Signify Bio.
Signify Bio's industry is
Biotechnology Research
Signify Bio's top competitors are
Danaher Corporation,
Actium Group,
Stereo Biotherapeutics,
Recode Therapeutics,
Brightedge - American Cancer Society,
Taysha Gene Therapies,
Aramis Biotechnologies,
Beam Therapeutics,
Allay Therapeutics,
Vertex Pharmaceuticals.
Signify Bio's categories are Biotechnology Research
Signify Bio's founding year is 2024
